πŸ‡ΊπŸ‡Έ FDA
Patent

US 12275684

Methods for making and using endoxifen

granted A61KA61K45/06A61K9/0053

Quick answer

US patent 12275684 (Methods for making and using endoxifen) held by ATOSSA THERAPEUTICS, INC. expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ATOSSA THERAPEUTICS, INC.
Grant date
Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
98
CPC classes
A61K, A61K45/06, A61K9/0053, A61P, A61P35/00